Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
42
PTGX Quote, Financials, Valuation and Earnings
Last price:
$89.05
Seasonality move
:
29.24%
Day range:
$87.47 - $89.47
52-week range:
$33.70 - $96.54
Dividend yield:
0%
P/E ratio:
140.11x
P/S ratio:
27.21x
P/B ratio:
8.59x
Volume:
329.1K
Avg. volume:
979.9K
1-year change:
126.06%
Market cap:
$5.5B
Revenue:
$434.4M
EPS (TTM):
$0.63
Earnings Data
Next earnings date for PTGX
Feb 20
2026
Most recent earnings per share
-$0.62
Beat by $0.03
(Nov 6/2025)
Consensus Estimate
-$0.64
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PTGX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/20/2026 | Q4 | $34.9M | -- | -- | -$0.56 | -- |
| 11/06/2025 | Q3 | $4.1M | $4.7M | -$0.62 | -$0.64 | $0.03 |
| 08/06/2025 | Q2 | $8.3M | $5.5M | -$0.55 | -$0.52 | -$0.02 |
| 05/05/2025 | Q1 | $30.4M | $28.3M | -$0.19 | $0.11 | -$0.30 |
| 02/21/2025 | Q4 | $56.6M | $170.6M | $1.98 | $0.25 | $1.73 |
| 11/07/2024 | Q3 | $1.8M | $4.7M | -$0.54 | -$0.53 | -$0.01 |
| 08/06/2024 | Q2 | $6.7M | $4.2M | -$0.50 | -$0.41 | -$0.09 |
| 05/07/2024 | Q1 | $120M | $255M | $3.26 | $1.60 | $1.66 |
| 02/27/2024 | Q4 | $30M | $60M | $0.44 | -$0.18 | $0.62 |
| 11/02/2023 | Q3 | -- | -- | -$0.58 | -$0.70 | $0.13 |
| 08/03/2023 | Q2 | -- | -- | -$0.68 | -- | -- |
| 05/04/2023 | Q1 | -- | -- | -$0.67 | -- | -- |
| 03/15/2023 | Q4 | -- | -- | -$0.69 | -- | -- |
| 11/08/2022 | Q3 | -- | -- | -$0.64 | -- | -- |
| 08/04/2022 | Q2 | -- | $859K | -$0.84 | -- | -- |
| 05/04/2022 | Q1 | -- | $25.7M | -$0.43 | -- | -- |
| 02/28/2022 | Q4 | -- | $8.6M | -$0.77 | -- | -- |
| 11/03/2021 | Q3 | -- | $10.3M | -$0.70 | -- | -- |
| 08/04/2021 | Q2 | -- | $2.3M | -$0.69 | -- | -- |
| 05/04/2021 | Q1 | -- | $6.2M | -$0.54 | -- | -- |
| 03/10/2021 | Q4 | -- | $5.7M | -$0.48 | -- | -- |
| 11/04/2020 | Q3 | -- | $13.1M | -$0.21 | -- | -- |
| 08/06/2020 | Q2 | -- | $6.2M | -$0.59 | -- | -- |
| 05/07/2020 | Q1 | -- | $3.6M | -$0.72 | -- | -- |
| 03/10/2020 | Q4 | -- | $2.7M | -$0.63 | -- | -- |
| 11/06/2019 | Q3 | -- | $4.1M | -$0.61 | -- | -- |
| 08/07/2019 | Q2 | -- | -$8.2M | -$1.18 | -- | -- |
| 05/08/2019 | Q1 | -- | $1.6M | -$0.58 | -- | -- |
| 03/12/2019 | Q4 | -- | $2.4M | -$0.57 | -- | -- |
| 11/06/2018 | Q3 | -- | $6.1M | -$0.38 | -- | -- |
| 08/07/2018 | Q2 | -- | $11.7M | -$0.41 | -- | -- |
| 05/09/2018 | Q1 | -- | $10.8M | -$0.36 | -- | -- |
| 03/07/2018 | Q4 | -- | $11.3M | -$0.15 | -- | -- |
| 11/06/2017 | Q3 | -- | $8.8M | -$0.29 | -- | -- |
| 08/08/2017 | Q2 | -- | -- | -$0.89 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.84 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.67 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.87 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$0.44 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.68 | -- | -- |
Protagonist Therapeutics, Inc. Earnings Questions
-
How Much did Protagonist Therapeutics, Inc. Generate in Revenue Last Quarter?
Protagonist Therapeutics, Inc. reported $4.7M worth of top line sales in its most recent quarter.
-
Did Protagonist Therapeutics, Inc. Beat Earnings Last Quarter?
Protagonist Therapeutics, Inc. announced earnings per share of -$0.62 which represents a beat of analyst forecast a -$0.64 per share.
-
Is Protagonist Therapeutics, Inc. Profitable?
Protagonist Therapeutics, Inc. reported $4.4M that represents $0.07 per share over the last quarter.
-
What is the Analyst Consensus for Protagonist Therapeutics, Inc. EPS Next Year?
Protagonist Therapeutics, Inc.'s earnings are forecast to decrease from $4.23 per share to $2.63 per share next year representing a decrease of -59.85%.
-
When is Protagonist Therapeutics, Inc.'s Earnings Date?
Protagonist Therapeutics, Inc.'s next earnings date is February 20, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
